ロード中...
Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)
BACKGROUND: In the treatment for glioblastoma (GBM), treatment modalities, such as bevacizumab (BEV) and carmustine wafers implants have been approved in Japan since 2013. However, it is unclear whether such a trend in treatment complexity can accelerate treatment centralization. The aim of this stu...
保存先:
| 出版年: | Int J Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Singapore
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286941/ https://ncbi.nlm.nih.gov/pubmed/33974184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-021-01929-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|